logo

For the Inventor, By the Inventor

Calabasas, CA, United States of America

Guangping Zhang

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:

goldMedal16 out of 1,224 
 
Medtronic Minimed, Inc.
 patents

Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 12465617 - Methods and systems for inhibiting foreign-body responses in diabetic patients (2025-11-11),
2. 12442786 - Sensors for 3-hydroxybutyrate detection (2025-10-14),
3. 12208181 - Medication infusion components and systems (2025-01-28),
4. 12201752 - Medication infusion components and systems (2025-01-21),
5. 12042284 - Implantable polymer surfaces exhibiting reduced in vivo inflammatory responses (2024-07-23),
6. 11944784 - Combined analyte sensor and infusion set (2024-04-02),
7. 11786673 - Fluid conduit assembly with gas trapping filter in the fluid flow path (2023-10-17),
8. 11672910 - Infusion devices and fluid identification apparatuses and methods (2023-06-13),
9. 11439352 - Medical device with adhesive patch longevity (2022-09-13),
10. 11207463 - Apparatuses, systems, and methods for identifying an infusate in a reservoir of an infusion device (2021-12-28),
11. 11197949 - Medication infusion components and systems (2021-12-14),
12. 11090446 - Fluid conduit assembly with gas trapping filter in the fluid flow path (2021-08-17),
13. 10828419 - Infusion set with pivoting metal cannula and strain relief (2020-11-10),
14. 10646649 - Infusion devices and fluid identification apparatuses and methods (2020-05-12),
15. 10517892 - Methods and systems for inhibiting foreign-body responses in diabetic patients (2019-12-31),

Title: Innovations by Guangping Zhang

Introduction

Guangping Zhang is a notable inventor based in Calabasas, CA, with a significant contribution to the field of medical technology. He holds 16 patents that focus on improving the management of diabetes and enhancing patient care through innovative sensor systems and medication infusion technologies.

Latest Patents

One of his latest inventions is a sensor designed for the detection of 3-hydroxybutyrate. This amperometric analyte sensor system comprises electrodes that monitor in vivo levels of 3-hydroxybutyrate, and optionally glucose, to aid in the management of diabetic ketoacidosis. The invention also includes various compositions, elements, and methods that enhance the functionality of these sensor systems.

Another significant patent involves medication infusion components and systems, which are essential for delivering medications such as insulin. These components are designed to infuse insulin into diabetic patients over a period exceeding four days. The system includes a cannula for subcutaneous insertion, a fluid conduit for delivering the insulin solution, and a depot that contains materials to mitigate site loss and inflammation during infusion.

Career Highlights

Guangping Zhang is currently employed at Medtronic Minimed, Inc., where he continues to develop innovative solutions for diabetes management. His work has significantly impacted the way insulin is delivered to patients, improving their quality of life.

Collaborations

He collaborates with talented professionals in his field, including Sarnath Chattaraj and Kiem H Dang, to drive advancements in medical technology.

Conclusion

Guangping Zhang's contributions to the field of medical technology through his patents and innovations demonstrate his commitment to improving patient care and diabetes management. His work continues to influence the industry and enhance the lives of many individuals living with diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…